Pixilab
Home › Companies › Biotechnology, Health Care, Medical Device, Therapeutics › LiMM Therapeutics

LiMM Therapeutics

LiMM Therapeutics is a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells.

LiMM Therapeutics is active in the biotechnology, health care, medical device, therapeutics space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.

Within the biotechnology, health care, medical device, therapeutics space, the company focuses on its core offering rather than a broad product line.

Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).

Directory data places it at the Grant stage.

The company reports a headcount in the c_00011_00050 range.

Public records show total funding of about $7M.

SectorBiotechnology, Health Care, Medical Device, Therapeutics
HeadquartersEuropean Union (EU), Europe, Middle East, and Africa (EMEA)
CountryFR
Founded2017
Employeesc_00011_00050
Stagegrant
Total funding$7,000,000

Website: www.limmtx.com

Browse related

More Biotechnology, Health Care, Medical Device, Therapeutics companies Companies in FR Companies founded in 2017
Full contact details are available to registered Pixilab members.
Create a free account